Bruno Andrade is currently a clinical research fellow in human immunology at the Laboratory of Parasitic Diseases, National Institutes of Health, United States of America. Dr. Andrade started his career working as undergraduate student in the Laboratory of Microbiology and Immunoregulation, Oswaldo Cruz Foundation, Brazil. During this period, he had an outstanding performance as a young researcher in the Brazilian Scientific Initiation Program, authoring a number of publications in top-quality journals in the area of Tropical Medicine. After obtaining his MD degree, Dr. Andrade pursued a PhD title, as usual in Brazil. His PhD Thesis in malaria resulted in several important publications with novel and relevant information in the field of malaria caused by Plasmodium vivax. His PhD work resulted in more than 10 articles published in top journals from different research fields. The quality of his work was recognized by two national prizes in Brazil, from the Ministries of Education and Health. In 2010, Dr. Andrade initiated a postdoctoral fellowship at the NIH focusing in other infectious diseases with colossal burden on public health, tuberculosis and HIV/AIDS. Since then, Dr. Andrade has identified several candidate biomarkers for tuberculosis severity and AIDS progression, and helped the development of an innovative US-patented immunotherapeutic approach for human tuberculosis.
Dr. Andrade is firmly dedicated to provide scientific contributions that may lead to development of useful approaches to control infectious diseases with high impact on public health worldwide. He started his studies in leishmaniasis and malaria, both diseases exerting enormous burden on socioeconomic development in several countries. During the period he worked in Brazil, he joined a multidisciplinary team composed by researchers from different regions of the country. His work in the Brazilian Amazon helped the local health care providers to perform treatment of asymptomatic carries of Plasmodium in a highly endemic region, which contributed to a dramatic reduction of the incidence of new malaria cases. Once in USA, Dr. Andrade focused to understand immunological determinants of tuberculosis and AIDS, and to accomplish this aim he participated in the creation a network of strong collaborations involving several countries, including India, China, South Africa and Brazil, where biomarkers can be validated across different areas with unlike disease epidemiology.